Although the treatment of diabetes has improved a lot in recent years, especially with the use of continuous measurement systems, there is still much to improve and right now there are many companies that are developing new and effective solutions.
In the field of glucose monitoring, several companies are developing less invasive devices than traditional ones and that eliminate the need to perform puncture analysis on the finger.
Diamontech has developed a technology that uses an invisible infrared light beam to see the inside of its skin and count the glucose molecules.
Meanwhile, Medella Health is developing smart contact lenses capable of testing glucose levels in tears.The device can offer real -time glucose readings, sending the data to an application of your smartphone.
Similarly, various companies are developing solutions to improve the insulin delivery process.For example, Companion Medical, which was acquired by Medtronic in 2020, has developed a reusable intelligent insulin pen that uses Bluetooth technology to offer dose calculations and follow up.
Other companies such as Dreamed Diabetes and Capillary Biomedical have developed more complete solutions that offer both glucose control and insulin delivery systems based on algorithms.
Other disruptive companies are also working on new ways of treating diabetes.In the CRISPR field (gene edition), Crispr Therapeutics and Viacyte announced last year that the Canadian medical agency had approved its clinical trial application for VCTX210, a stem cell therapy edited by CRISPR designed to treat diabetes ofType 1 by improving insulin production.Genetic edition is considered one of the best possibilities to find a cure for the disease.
Microarn gene expression technology is another form of exploration phase technology.Rosvivo Therapeutics is developing a new treatment that uses microarn technology to reverse the pathology of type 2 diabetes. Its objective is to prevent diabetics from suffering the most common complications in the long term.
At present, areas of diagnosis, management and virtual attention are also developing great innovations.
In the field of diagnosis, Glyconics is creating a range of portable accessories that use infrared spectroscopy technology to diagnose the disease through changes in nail biomarkers.Regarding management, companies such as Fitterfly and Voted Health have developed digital therapies that help improve nutrition, physical exercise and behavioral habits to better control diabetes.
Finally, in the field of virtual attention, telemedicine platforms such as Teladoc Health have established specific diabetes care programs.
Together, technology is presented as decisive for the treatment of diabetes.